Hikma Pharmaceuticals PLC Annual Report 2014 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS continued 6.
PROFIT FOR THE YEAR Profit for the year has been arrived at after charging crediting : 2014 2013 $m $m Net foreign exchange losses gain 6 2 Depreciation and impairment of property, plant and equipment 49 49 Amortisation of intangible assets including software 18 18 Impairment of investment 16 Inventories: Cost of inventories recognised as an expense 378 354 Write-down of inventories 32 47 Staff costs see Note 7 344 319 The Group auditors remuneration on a worldwide basis was as below: 2014 2013 $m $m Audit of the Companys annual accounts 0.4 0.3 Audit of the Companys subsidiaries pursuant to legislation 1.2 1.2 Total audit fees 1.6 1.5 Audit-related services 0.2 0.2 Total audit and audit-related fees 1.8 1.7 Tax compliance services 0.1 0.1 Tax advisory services 0.4 0.1 Other services 0.4 Total non-audit fees 0.5 0.6 Total fees 2.3 2.3 Audit-related services relate to review procedures in respect of the interim financial information Other services include transaction services related to corporate transactions A description of the work of the Audit Committee is set out in the Audit Committee report on pages 74 to 80 and includes an explanation ofhow auditor objectivity and independence is safeguarded when non-audit services are provided by the auditor.
STAFF COSTS The average monthly number of employees including Executive Directors was: 2014 2013 Number Number Production 3,986 3,942 Sales and marketing 2,089 2,097 Research and development 223 205 General and administrative 841 823 7,139 7,067 140
